Showing results (1-10 of 69) with videos related to

Sort By:
Pageof 7
Expert Opinion on Therapeutic Patents|October 5, 2022
An updated patent review of rearranged during transfection (RET) kinase inhibitors (2016-present)Baku Acharya, Brendan Frett
RSC Medicinal Chemistry|August 4, 2022
FLT3 inhibitors for acute myeloid leukemia: successes, defeats, and emerging paradigmsBaku Acharya, Debasmita Saha, Daniel Armstrong, et al.
Journal of Medicinal Chemistry|August 17, 2021
Targeting Rearranged during Transfection in Cancer: A Perspective on Small-Molecule Inhibitors and Their Clinical DevelopmentDebasmita Saha, Katie Rose Ryan, Naga Rajiv Lakkaniga, et al.
The Journal of Pharmacology and Experimental Therapeutics|July 24, 2025
Transforming growth factor β receptor 1 and mitogen-activated protein 4 kinase 4 dual inhibitor, TK-850, reduces renal fibrosis in unilateral ureteral-obstructed miceHenry A Palfrey, Samaneh Goorani, Abhishek Mishra, et al.
Bioorganic & Medicinal Chemistry|May 14, 2024
Discovery of 9H-pyrimido[4,5-b]indole derivatives as dual RET/TRKA inhibitorsBaku Acharya, Debasmita Saha, Noemi Garcia Garcia, et al.
RSC Medicinal Chemistry|February 23, 2024
Kinase inhibitor macrocycles: a perspective on limiting conformational flexibility when targeting the kinome with small moleculesBaku Acharya, Debasmita Saha, Daniel Armstrong, et al.
Scientific Reports|August 28, 2024
Discovery of the DNA-PKcs inhibitor DA-143 which exhibits enhanced solubility relative to NU7441Zachary J Waldrip, Baku Acharya, Daniel Armstrong, et al.
Expert Opinion on Therapeutic Patents|June 12, 2025
An updated patent review of rearranged during transfection (RET) kinase inhibitors (2022-present)Daniel Armstrong, Maha Hanafi, Brendan Frett
Pageof 7